CELG
Celgene

Conference date: April 30, 2009 @ 6:00 AM Pacific Time

Analyst Conference summaries and reports available:

Celgene to Grow Rapidly [September 7, 2008]
Celgene Data for Revlimid, Vidaza, Amrubicin [June 15, 2008]
Celgene Optimism [February 4, 2008]

2009
Celgene analyst conference summary q4 2008
Celgence (CELG) analyst conference summary Q1 2009
 
 
01/29/2009
04/30/2009
 
 
Q4 2008
Q1 2009
 
 
2008
Celgene Analyst Conference Summary Q3 2008
Celgene analyst conference summary Q2 2008
Celgene q1 analyst conference summary 2008
Celgene analyst conference summary for Q 2007
10/23/2008
07/24/2008
05/08/2008
01/31/2008
Q3 2008
Q2 2008
Q1 2008
Q4 2007
2007
Celgene analyst conference summary Q3 2007
CELG Q2 2007
celg summary

10/25/2007
07/26/2007
05/03/2007

 02/01/2007
Q3 2007
Q2 2007
Q1 2007

 Q4 2006

Celgene is a biotechnology company; products include Thalomid, Revlimid and Ritalin.

Celgene (CELG) and Pharmion (PHRM) [November 24, 2007 blog]
Pharmion Acquisition [November 19, 2007 press release]
Celgene in Hypergrowth [May 23, 2007 blog]

I own this stock

Celgene Web site:

main page
investor page

Disclaimer: Our analyst summaries may include both our condensations of statements made by company representatives and our own analysis. They are not covered by any warranty. We cannot guarantee anything said by company representatives is true. We try not to make errors, but its possible. Before making or terminating an investment you should always verify any factual basis of your decision.